Evidence map›Paper›PMID 42359351›Full record

ArticleFrontiers in molecular biosciences2026

Stirring glycopeptides away from the constraints of solid-phase synthesis misconceptions.

Dror Ben Abba Amiel, Chaim Gilon, Mattan Hurevich

Abstract read
In one paragraph

Article in Frontiers in molecular biosciences, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

3 authors.

Dror Ben Abba AmielInstitute of Chemistry, Hebrew University of Jerusalem, Jerusalem, Israel.
Chaim GilonInstitute of Chemistry, Hebrew University of Jerusalem, Jerusalem, Israel.
Mattan HurevichInstitute of Chemistry, Hebrew University of Jerusalem, Jerusalem, Israel.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Glycosylation is one of the most prevalent post-translational modifications of proteins. Synthetic glycopeptides give access to protein fragments with well-defined glycosylation sites, providing a unique route to obtain relevant biochemical information. Since glycosylation can be extremely abundant and appear in different patterns, the assembly of glycopeptide libraries that manifest this variety is required. Several limitations in state-of-the-art solid-phase peptide synthesis make these processes less appropriate for the accelerated preparation of glycopeptides. Our lab has developed a highly-efficient method for glycopeptide synthesis, which employs high-shear mixing at a high temperature to obtain glycopeptides within minutes with minimal waste of building blocks. The development of this new process was not trivial. It encountered synthetic difficulties associated with the complexity of glycan chemistry, which were met by expanding the traditional technological boundaries and challenging common practices. In this perspective, we describe the thought process that has guided us through the development of this method. We illustrate the key role diffusion properties hold for the optimization of reactions and for streamlining and expediting the protocol. We then elaborate on how the ability to question some conceptual bottlenecks associated with SPPS conceptions was pivotal to the success of this project. We compare the presented study with other techniques that aim to accelerate the synthesis of glycopeptides. Finally, we describe the present and future possibilities of the strategy and how they may contribute to expanding the scope of glycopeptide research.

Indexed as

diffusionglycopeptidesmixingpost-translation modificationssolid-phase synthesis

Identifiers

PMID42359351
PMCPMC13290445

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.